Muscle Stimulation Devices Market Size to Exceed USD 1,059.0 Mn by 2032

The Muscle Stimulation Devices Market, estimated at USD 815.7 Mn in 2025, is expected to exhibit a CAGR of 3.8% and reach USD 1,059.0 Mn by 2032.

The industry is witnessing significant growth driven by rising demand for advanced, reliable, and cost-effective medical devices across diagnostic, therapeutic, and monitoring applications. Rapid advancements in device design, digital health integration, and adoption of minimally invasive technologies are reshaping the competitive landscape. Furthermore, supportive regulatory frameworks, increasing healthcare investments, and the growing focus on patient-centric care are expected to create new growth avenues for market players.

key market players are focused on adopting growth strategies such as acquisition and partnerships, which will drive the global muscle stimulation devices market. For instance, in March 2025, Hinge Health is Digital Musculoskeletal Clinic, is acquired the Enso Relief is a Medical Devices company headquarters in U.S., Its’s a clinically validated non-invasive, non-addictive technology used to help people with musculoskeletal (MSK) pain.

Global Muscle Stimulation Devices Market– Impact of Coronavirus (COVID-19) Pandemic

The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China) in the last months of 2025 as "coronavirus disease 2025" or COVID-19. This virus spread quickly and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.

COVID-19 affected the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to the lockdown, several countries such as India, China, Brazil, and others faced problems with regard to the transportation of drugs from one place to another.

COVID-19 had a positive impact on the global muscle stimulation devices market. For instance, in May 2025, Liberate Medical's VentFree Respiratory Muscle Stimulator received United States Food and Drug Administration emergency approval. The device delivers stimulation in a non-invasive fashion, and the therapy can be initiated immediately at the start of ventilation and continued until patients are weaned off ventilation. This reduces the time of ventilation of the patients. This is attributed to increasing musculoskeletal disorders, technological advancement, emphasis on pain management therapies in sports medicine, and growing preference among physiotherapists for the disorders as muscle stimulators help in reducing muscle spasms, reducing discomfort and pain, restoring muscle tone, and rehabilitating parts of the body.

Global Muscle Stimulation Devices Market: Key Developments

Additionally, workshops and seminars related to Pain management across the world to promote muscle stimulator device are expected to boost market growth during the forecast period. For instance, in February 2025, MED-EL Medical Electronics is a Australian provider of hearing implant systems, Introduced STIWELL Neurorehabilitation & Electrotherapy. It’s electrotherapy device offers a comprehensive therapy concept for rehabilitation after neurological & orthopaedic diseases. In the workshop, Practical application of EMG-triggered multi-channel electrical stimulation including electrode attachment, case examples optionally with patient and theoretical background knowledge.

Browse 34 Market Data Tables and 26 Figures spread through 176 Pages and in-depth TOC on “Global Muscle Stimulation Devices Market”- Forecast to 2032, Global Muscle Stimulation Devices Market, by Product Type (Transcutaneous Electrical Nerve Stimulation (TENS), Interferential Current Electrical Stimulation (IFC), Burst Mode Alternating Current (BMAC), Neuromuscular Electrical Stimulation (NMES)), By Application (Pain Management, Neurological and Movement Disorder Management, Musculoskeletal Disorder Management), By End user (Hospitals, Physiotherapy Clinics, Sports Clinics, Home Care), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

To know the latest trends and insights prevalent in this market, click the link below:

https://www.coherentmarketinsights.com/market-insight/muscle-stimulation-devices-market-3518

Key Takeaways of the Global Muscle Stimulation Devices Market:

The global muscle stimulation devices market is expected to exhibit a CAGR of 3.8% during the forecast period.The merger with emerging economies offers lucrative growth opportunities for players in the global muscle stimulation devices market. The spread of transcutaneous electrical nerve stimulation (TENS) technologies has been driven by high public awareness in developed economies such as the U.S. and Europe.
Among application, The musculoskeletal disorder management segment is expected to growth in the global musculoskeletal disorder management segment over the forecast period. For instance, In February 2025, Biohaven Pharmaceutical Holding Company Ltd, is a pharmaceutical company in U.S. and Pfizer Inc. is an pharmaceutical and biotechnology corporation, reported that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion for Rimegepant, a calcitonin gene-related peptide (CGRP) receptor antagonist. Hence, Musculoskeletal disorder management segment is expected to witness a strong growth in coming years.
Among Product Type, The Transcutaneous Electrical Nerve Stimulation (TENS) segment is expected to hold a dominant position in the global muscle stimulation devices market during the forecast period and this is attributed to the technological advancements in the field of muscle stimulation devices. For instance, In December 2025, CUTERA, INC. is a aesthetics device company, announced the launch of the next generation of truSculpt flex. The truSculpt flex+ rapid treatment mode takes Cutera's proprietary Multi-Directional Stimulation to the next level offering the same toning, firming and strengthening results in a fraction of the treatment time.
Among region, North America is expected to be the dominant region in the global muscle stimulation devices market, owing to the increasing launch of products. For instance, in April 2025, StimaWELL North America Inc. is medical device company, launched multiple new products and advancements for its wave E-stim therapy, transcutaneous electrical nerve, muscle stimulator (EMS) for rapid and effective back and neck pain relief.
Major players operating in the global Muscle Stimulation Devices market include DJO Global Inc., Zynex Inc., Neurometrix Inc., R.S. Medical Inc.,Omron Corporation Medtronic plc., Abbott., Boston Scientific Corporation., BTL Corporate., Nevro Corp., Cogentix Medical and BioMedical Life Systems